Great general response by the chemist (owner), but it seems your specific question to her “how are sales” was not answered. Did you wonder why? Perhaps her Evolis sales are a secret, or she didn’t hear or understand your question or it’s just the vague communication norm these days.
You could assume from her endorsement that there are some sales from that chemist but curiously there is virtually no information, even from CDY, on Evolis sales by Australian pharmacies. Apart from the Priceline chain, best guess is that Evolis sales by the other 1,800 chemists averages less than $90 per month.
This points to huge scope for higher sales out of Aussie chemists once some serious attention is given to it.
- Forums
- ASX - By Stock
- AN1
- 2018 - The Year of the BioTechs
2018 - The Year of the BioTechs, page-55
-
- There are more pages in this discussion • 621 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AN1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AN1 (ASX) Chart |
Day chart unavailable
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online